Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The prognostic value of G8 for functional decline.

Chakiba C, Bellera C, Etchepare F, Mathoulin-Pelissier S, Rainfray M, Soubeyran P.

J Geriatr Oncol. 2019 Jan 9. pii: S1879-4068(18)30265-0. doi: 10.1016/j.jgo.2018.12.004. [Epub ahead of print]

PMID:
30638869
2.

Identification of clinical parameters predictive of one-year survival using two geriatric tools in clinically fit older patients with hematological malignancies: Major impact of cognition.

Dubruille S, Libert Y, Roos M, Vandenbossche S, Collard A, Meuleman N, Maerevoet M, Etienne AM, Reynaert C, Razavi D, Bron D.

J Geriatr Oncol. 2015 Sep;6(5):362-9. doi: 10.1016/j.jgo.2015.07.006. Epub 2015 Aug 12.

3.

Performance of two geriatric screening tools in older patients with cancer.

Kenis C, Decoster L, Van Puyvelde K, De Grève J, Conings G, Milisen K, Flamaing J, Lobelle JP, Wildiers H.

J Clin Oncol. 2014 Jan 1;32(1):19-26. doi: 10.1200/JCO.2013.51.1345. Epub 2013 Nov 25.

PMID:
24276775
4.

Validation of the G8 screening tool in older patients with aggressive haematological malignancies.

Velghe A, Petrovic M, De Buyser S, Demuynck R, Noens L.

Eur J Oncol Nurs. 2014 Dec;18(6):645-8. doi: 10.1016/j.ejon.2014.05.006. Epub 2014 Jun 20.

PMID:
24954768
5.

Geriatric oncology screening tools for CGA-based interventions: results from a phase II study of geriatric assessment and management for older adults with cancer.

Yokom DW, Alibhai SMH, Sattar S, Krzyzanowska MK, Puts MTE.

J Geriatr Oncol. 2018 Nov;9(6):683-686. doi: 10.1016/j.jgo.2018.03.001. Epub 2018 Mar 12.

PMID:
29540293
6.

Impact of geriatric assessment on the management of older adults with head and neck cancer: A pilot study.

Neve M, Jameson MB, Govender S, Hartopeanu C.

J Geriatr Oncol. 2016 Nov;7(6):457-462. doi: 10.1016/j.jgo.2016.05.006. Epub 2016 Jun 13.

PMID:
27313080
7.

Geriatric screening results and the association with severe treatment toxicity after the first cycle of (radio)chemotherapy.

Baitar A, Van Fraeyenhove F, Vandebroek A, De Droogh E, Galdermans D, Mebis J, Schrijvers D.

J Geriatr Oncol. 2014 Apr;5(2):179-84. doi: 10.1016/j.jgo.2013.12.004. Epub 2014 Jan 17.

PMID:
24495700
8.

Prospective evaluation of the G8 screening tool for prognostication of survival in elderly patients with lung cancer: A single-institution study.

Agemi Y, Shimokawa T, Sasaki J, Miyazaki K, Misumi Y, Sato A, Aida S, Ishii M, Nakamura Y, Naoki K, Okamoto H.

PLoS One. 2019 Jan 17;14(1):e0210499. doi: 10.1371/journal.pone.0210499. eCollection 2019.

9.

Evaluation of the Groningen Frailty Indicator and the G8 questionnaire as screening tools for frailty in older patients with cancer.

Baitar A, Van Fraeyenhove F, Vandebroek A, De Droogh E, Galdermans D, Mebis J, Schrijvers D.

J Geriatr Oncol. 2013 Jan;4(1):32-8. doi: 10.1016/j.jgo.2012.08.001. Epub 2012 Aug 24.

PMID:
24071490
10.

[Cancer treatment in elderly patients: evidence and clinical research].

Repetto L, Luciani A.

Recenti Prog Med. 2015 Jan;106(1):23-7. doi: 10.1701/1740.18952. Italian.

PMID:
25621776
11.

Relevance of G8 scale in referring elderly patients with aortic stenosis requiring a TAVI for a geriatric consultation.

de Thézy A, Lafargue A, d'Arailh L, Dijos M, Leroux L, Salles N, Rainfray M.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Dec 1;15(4):357-363. doi: 10.1684/pnv.2017.0697.

PMID:
29187325
12.

Comprehensive Geriatric Assessment in Men Aged 70 Years or Older with Localised Prostate Cancer Undergoing Radical Radiotherapy.

Osborne GEC, Appleyard SA, Gilbert DC, Jones CI, Lorimer C, Villanueva M, Peasgood E, Robinson A, Nikapota A, Ring A.

Clin Oncol (R Coll Radiol). 2017 Sep;29(9):609-616. doi: 10.1016/j.clon.2017.05.003. Epub 2017 Jun 4.

PMID:
28592379
13.

Prognostic value of the G8 and modified-G8 screening tools for multidimensional health problems in older patients with cancer.

Martinez-Tapia C, Paillaud E, Liuu E, Tournigand C, Ibrahim R, Fossey-Diaz V, Culine S, Canoui-Poitrine F, Audureau E; ELCAPA Study Group.

Eur J Cancer. 2017 Sep;83:211-219. doi: 10.1016/j.ejca.2017.06.027. Epub 2017 Jul 24.

PMID:
28750273
14.

Comprehensive geriatric assessment predicts mortality and adverse outcomes in hospitalized older adults.

Avelino-Silva TJ, Farfel JM, Curiati JA, Amaral JR, Campora F, Jacob-Filho W.

BMC Geriatr. 2014 Dec 3;14:129. doi: 10.1186/1471-2318-14-129.

15.

Risk stratification for surgical outcomes in older colorectal cancer patients using ISAR-HP and G8 screening tools.

Souwer ETD, Verweij NM, van den Bos F, Bastiaannet E, Slangen RME, Steup WH, Hamaker ME, Portielje JEA.

J Geriatr Oncol. 2018 Mar;9(2):110-114. doi: 10.1016/j.jgo.2017.09.003. Epub 2017 Nov 10.

PMID:
29129470
16.

The added value of an assessment of the patient's hand grip strength to the comprehensive geriatric assessment in G8-abnormal older patients with cancer in routine practice.

Lycke M, Ketelaars L, Martens E, Lefebvre T, Pottel H, Van Eygen K, Cool L, Pottel L, Kenis C, Schofield P, Boterberg T, Debruyne PR.

J Geriatr Oncol. 2019 Jan 10. pii: S1879-4068(18)30125-5. doi: 10.1016/j.jgo.2019.01.001. [Epub ahead of print]

PMID:
30639266
17.

Predictive values of two frailty screening tools in older patients with solid cancer: a comparison of SAOP2 and G8.

Russo C, Giannotti C, Signori A, Cea M, Murialdo R, Ballestrero A, Scabini S, Romairone E, Odetti P, Nencioni A, Monacelli F.

Oncotarget. 2018 Oct 12;9(80):35056-35068. doi: 10.18632/oncotarget.26147. eCollection 2018 Oct 12.

18.

Geriatric screening tools are of limited value to predict decline in functional status and quality of life: results of a cohort study.

Deckx L, van den Akker M, Daniels L, De Jonge ET, Bulens P, Tjan-Heijnen VC, van Abbema DL, Buntinx F.

BMC Fam Pract. 2015 Mar 3;16:30. doi: 10.1186/s12875-015-0241-x.

19.

Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.

Martinez-Tapia C, Canoui-Poitrine F, Bastuji-Garin S, Soubeyran P, Mathoulin-Pelissier S, Tournigand C, Paillaud E, Laurent M, Audureau E; ELCAPA Study Group.

Oncologist. 2016 Feb;21(2):188-95. doi: 10.1634/theoncologist.2015-0326. Epub 2016 Jan 13.

20.

The role of Geriatric screening tool (G8) in predicting side effect in older patients during therapy with aromatase inhibitor.

Dottorini L, Catena L, Sarno I, Di Menna G, Marte A, Novelli E, Rusca C, Bajetta E.

J Geriatr Oncol. 2018 Oct 14. pii: S1879-4068(18)30266-2. doi: 10.1016/j.jgo.2018.10.007. [Epub ahead of print]

PMID:
30333087

Supplemental Content

Support Center